Literature DB >> 28513200

HIV-infected individuals who use alcohol and other drugs, and virologic suppression.

Seonaid Nolan1, Alexander Y Walley2, Timothy C Heeren3, Gregory J Patts4, Alicia S Ventura2, Meg M Sullivan5, Jeffrey H Samet2,6, Richard Saitz2,6.   

Abstract

People living with HIV (PLWH) on antiretroviral therapy (ART) who use substances were examined to (a) describe those with virologic control and (b) determine which substance use-factors are associated with lack of virologic control. Participants were adult PLWH taking ART with either past 12-month DSM-IV substance dependence or past 30-day alcohol or illicit drug use. Substance use factors included number of DSM-IV alcohol or drug dependence criteria and past 30-day specific substance use. Associations with HIV viral load (HVL) (<200 vs. ≥200 copies/mL) were tested using logistic regression models. Multivariable analyses adjusted for age, sex, homelessness and anxiety or depression. Participants (n = 202) were median age 50 years, 66% male, 51% African American and 75% self-reported ≥90% past 30-day ART adherence. Though HVL suppression (HVL <200 copies/mL) was achieved in 78% (158/202), past 30-day substance use was common among this group: 77% cigarette use; 51% heavy alcohol use; 50% marijuana; 27% cocaine; 16% heroin; and 15% illicit prescription opioid use. After adjusting for covariates, specific substance use was not associated with a detectable HVL, however number of past 12-month DSM-IV drug dependence criteria was (adjusted odds ratio = 1.23 for each additional criterion, 95% CI: 1.04-1.46). Three-quarters of a substance-using cohort of PLWH receiving ART had virologic control and ≥90% ART adherence. Substance dependence criteria (particularly drug dependence), not specifically substance use, were associated with lack of virologic control. Optimal HIV outcomes can be achieved by individuals who use alcohol or drugs and addressing symptoms of substance dependence may improve HIV-related outcomes.

Entities:  

Keywords:  HIV; antiretroviral; injection drug use; medication adherence; substance use

Mesh:

Year:  2017        PMID: 28513200      PMCID: PMC5543330          DOI: 10.1080/09540121.2017.1327646

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  47 in total

1.  Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.

Authors:  Julia H Arnsten; Penelope A Demas; Richard W Grant; Marc N Gourevitch; Homayoon Farzadegan; Andrea A Howard; Ellie E Schoenbaum
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

2.  Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.

Authors:  David J Moore; Kaitlin Blackstone; Steven Paul Woods; Ronald J Ellis; J Hampton Atkinson; Robert K Heaton; Igor Grant
Journal:  AIDS Care       Date:  2012-04-24

Review 3.  Substance use: impact on adherence and HIV medical treatment.

Authors:  Adam Gonzalez; Jennifer Barinas; Conall O'Cleirigh
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

4.  Drug use and medication adherence among HIV-1 infected individuals.

Authors:  Charles H Hinkin; Terry R Barclay; Steven A Castellon; Andrew J Levine; Ramani S Durvasula; Sarah D Marion; Hector F Myers; Douglas Longshore
Journal:  AIDS Behav       Date:  2007-03

5.  Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy.

Authors:  K E Poundstone; R E Chaisson; R D Moore
Journal:  AIDS       Date:  2001-06-15       Impact factor: 4.177

6.  Reliability of alcohol abusers' self-reports of drinking behavior.

Authors:  L C Sobell; S A Maisto; M B Sobell; A M Cooper
Journal:  Behav Res Ther       Date:  1979

7.  Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.

Authors:  Mette Vang Larsen; Lars Haukali Omland; Jan Gerstoft; Birgit T Røge; Carsten Schade Larsen; Gitte Pedersen; Niels Obel; Gitte Kronborg
Journal:  Scand J Infect Dis       Date:  2010-09-15

8.  Psychiatric Distress, Drug Use, and HIV Viral Load Suppression in Russia.

Authors:  A Ustinov; A Suvorova; A Belyakov; A Makhamatova; O Levina; E Krupitsky; D Lioznov; L Niccolai; R Heimer
Journal:  AIDS Behav       Date:  2016-08

9.  Associations between alcohol use disorders and adherence to antiretroviral treatment and quality of life amongst people living with HIV/AIDS.

Authors:  Bach Xuan Tran; Long Thanh Nguyen; Cuong Duy Do; Quyen Le Nguyen; Rachel Marie Maher
Journal:  BMC Public Health       Date:  2014-01-10       Impact factor: 3.295

10.  Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes.

Authors:  Dominique Costagliola; Bruno Ledergerber; Carlo Torti; Ard van Sighem; Daniel Podzamczer; Amanda Mocroft; Maria Dorrucci; Bernard Masquelier; Andrea de Luca; Klaus Jansen; Stephane De Wit; Niels Obel; Gerd Fätkenheuer; Giota Touloumi; Cristina Mussini; Antonella Castagna; Cristoph Stephan; Federico García; Robert Zangerle; Xavier Duval; Santiago Perez-Hoyos; Laurence Meyer; Jade Ghosn; Céline Fabre-Colin; Jesper Kjaer; Genevieve Chêne; Jesper Grarup; Andrew Phillips; Rebecca Lodwick; Carlo Torti; Maria Dorrucci; Huldrych F Günthard; Claudia Michalik; George Chrysos; Antonella Castagna
Journal:  J Infect Dis       Date:  2012-12-07       Impact factor: 5.226

View more
  24 in total

1.  AWARENESS: Development of a cognitive-behavioral intervention to address intersectional minority stress for sexual minority men living with HIV who use substances.

Authors:  Annesa Flentje
Journal:  Psychotherapy (Chic)       Date:  2019-08-01

Review 2.  Substance Use and Adherence to Antiretroviral Therapy: What Is Known and What Is Unknown.

Authors:  M Eugenia Socias; M-J Milloy
Journal:  Curr Infect Dis Rep       Date:  2018-07-31       Impact factor: 3.725

Review 3.  Brain-behavior relations and effects of aging and common comorbidities in alcohol use disorder: A review.

Authors:  Edith V Sullivan; Adolf Pfefferbaum
Journal:  Neuropsychology       Date:  2019-09       Impact factor: 3.295

4.  Methamphetamine use drives decreases in viral suppression for people living with HIV released from a large municipal jail: Results of the LINK LA clinical trial.

Authors:  David Goodman-Meza; Steve Shoptaw; Robert E Weiss; Terry Nakazono; Nina T Harawa; Sae Takada; Wendy H Garland; William E Cunningham
Journal:  Drug Alcohol Depend       Date:  2019-07-16       Impact factor: 4.492

Review 5.  Synthetic Opioid Use and Common Injection-associated Viruses: Expanding the Translational Research Agenda.

Authors:  Jason T Blackard; Jennifer L Brown; Michael S Lyons
Journal:  Curr HIV Res       Date:  2019       Impact factor: 1.581

6.  Enhancing patient navigation with contingent financial incentives for substance use abatement in persons with HIV and substance use.

Authors:  Maxine L Stitzer; Natalie Gukasyan; Tim Matheson; James L Sorensen; Daniel J Feaster; Rui Duan; Lauren Gooden; Carlos Del Rio; Lisa R Metsch
Journal:  Psychol Addict Behav       Date:  2019-08-22

7.  Injection and Non-Injection Drug Use Among Adults with Diagnosed HIV in the United States, 2015-2018.

Authors:  Kathleen Wu; Yunfeng Tie; Sharoda Dasgupta; Linda Beer; Ruthanne Marcus
Journal:  AIDS Behav       Date:  2021-09-18

8.  The Depression Treatment Cascade: Disparities by Alcohol Use, Drug Use, and Panic Symptoms Among Patients in Routine HIV Care in the United States.

Authors:  Bethany L DiPrete; Brian W Pence; Angela M Bengtson; Richard D Moore; David J Grelotti; Conall O'Cleirigh; Riddhi Modi; Bradley N Gaynes
Journal:  AIDS Behav       Date:  2019-03

9.  Improvements in Retention in Care and HIV Viral Suppression Among Persons with HIV and Comorbid Mental Health Conditions: Patient-Centered HIV Care Model.

Authors:  Kathy K Byrd; Felicia Hardnett; John G Hou; Patrick G Clay; Sumihiro Suzuki; Nasima M Camp; Michael D Shankle; Paul J Weidle; Michael S Taitel
Journal:  AIDS Behav       Date:  2020-12

Review 10.  An update on drug-drug interactions between antiretroviral therapies and drugs of abuse in HIV systems.

Authors:  Nuti Desai; Leah Burns; Yuqing Gong; Kaining Zhi; Asit Kumar; Nathan Summers; Santosh Kumar; Theodore J Cory
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-08-31       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.